industry-designed clinical trial (if applicable for processing via Office of Research rather than UPMC OSPARS). Please note that no research is to be conducted a CDA/NDA. CDAs/NDAs are generally for the discussion and planning of future research endeavors. 10. What information is the other party disclosing information to you? [insert information] * In order for appropriate language to be included in the CDA, we must know what information will be disclosed to you. As with all types of agreements, it is important that the confidential information be as narrowly defined as possible. 11. What non-public information are you disclosing to the other party? [insert information] *If the University PI will be disclosing confidential information, the Office of Research must ensure that the proposed CDA/NDA contemplates the mutual exchange of information rather than simply the one-way exchange of information. In addition, the Office of Research must understand the nature of the information you will be disclosing so that appropriate protections can be added to the CDA/NDA. For example, if the confidential information relates to a provisional patent, we may need to add additional language to the CDA. 12. If you are disclosing non-public information, did you develop this information or do you have the full rights to disclose this information: No (please explain)/ Yes * This question is to ensure that you have the right to disclose the information you desire to disclose. This may be especially important if you did not generate the information you plan to share. 13. If you are disclosing non-public information, is it related to a potentially patentable invention or discovery? No/Yes (information needed) If Yes, please provide the name of the Office of Technology Management staff person with whom you have been working. 14. If this CDA relates to any other agreement, please list all that apply, i.e. Sponsored Research Agreement, Government or Other Grant, CDA, License, MTA, Other Agreement
industry-designed clinical trial (if applicable for processing via Office of Research rather than UPMC OSPARS). Please note that no research is to be conducted a CDA/NDA. CDAs/NDAs are generally for the discussion and planning of future research endeavors. 10. What information is the other party disclosing information to you? [insert information] * In order for appropriate language to be included in the CDA, we must know what information will be disclosed to you. As with all types of agreements, it is important that the confidential information be as narrowly defined as possible. 11. What non-public information are you disclosing to the other party? [insert information] *If the University PI will be disclosing confidential information, the Office of Research must ensure that the proposed CDA/NDA contemplates the mutual exchange of information rather than simply the one-way exchange of information. In addition, the Office of Research must understand the nature of the information you will be disclosing so that appropriate protections can be added to the CDA/NDA. For example, if the confidential information relates to a provisional patent, we may need to add additional language to the CDA. 12. If you are disclosing non-public information, did you develop this information or do you have the full rights to disclose this information: No (please explain)/ Yes * This question is to ensure that you have the right to disclose the information you desire to disclose. This may be especially important if you did not generate the information you plan to share. 13. If you are disclosing non-public information, is it related to a potentially patentable invention or discovery? No/Yes (information needed) If Yes, please provide the name of the Office of Technology Management staff person with whom you have been working. 14. If this CDA relates to any other agreement, please list all that apply, i.e. Sponsored Research Agreement, Government or Other Grant, CDA, License, MTA, Other Agreement